First human test of new leukemia pill halted
Disease control
Terminated
This was an early safety study for a new oral drug called SGR-2921, designed for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has returned or not responded to prior treatments. The main goal was to find the highest safe dose and understand how t…
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC